A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma

Journal of Neuro-Oncology

Volumn 82, Issue 2, 2007, Pages 207-209

  Chamberlain, Marc C ^a   Chalmers, Lisa ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Deferred radiotherapy; Dose dense temozolomide; Elderly patients; Glioblastoma

Indexed keywords

ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; BEVACIZUMAB; CARBOPLATIN; DEXAMETHASONE; IRINOTECAN; TEMOZOLOMIDE;

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE FREE SURVIVAL; DRUG EFFICACY; ELDERLY CARE; FEMALE; GLIOBLASTOMA; HUMAN; LOW DRUG DOSE; LUNG EMBOLISM; LYMPHOCYTOPENIA; MALE; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PILOT STUDY; POSTOPERATIVE PERIOD; SINGLE DRUG DOSE; THROMBOCYTOPENIA; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; MALE; PILOT PROJECTS; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33947200238     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-006-9269-z     Document Type: Article

References (10)

1. Stupp R, Mason WP, van den Bent M et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Eng J Med 352:987-996
2. Mirimanoff R-O, Gorlia T, Mason W et al (2006) Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol 24(16):2563-2569
3. Glantz M, Chamberlain M, Liu Q, Litofsky NS, Recht LD (2003) Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. Cancer 97:2262-2266
4. Macdonald DR, Cascino TL, Schold SC et al (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280
5. Talarico L, Chen G, Pazdur R. (2004) Enrollment of elderly patients in clinical trials for cancer drug registration: A 7-year experience by the US food and drug administration. J Clin Oncol 22:4626-4631
6. Ohgaki H, Dessen P, Jourde B et al (2005) Genetic pathways to glioblastoma: A population-based study. Cancer Res 64:6892-6899
7. Chang SM, Parney IF, Huang W, et al. (2005) Glioma outcomes project investigators. Patterns of care for adults with newly diagnosed malignant glioma. JAMA 2; 293(5):557-564
8. Rao W, Brasher PM, Bauman G et al (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial. J Clin Oncol 22(9):1583-1588
9. Buttolo L, Giunta F, Ferrari VD et al (2006) Alternative schedules of adjuvant temozolomide in glioblastoma multiforme; a 6-year experience. Alternative schedules of TMZ for newly diagnosed GBM. Proc ASCO 24(18S):60s (abstract)
10. Hegi M, Diserens AC, Gorlia T et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. NEJM 352(10):997-1003